Intranasal dexmedetomidine for sedation for pediatric computed tomography imaging.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 25748567.
- Also identified by DOI 10.1016/j.jpeds.2015.01.036.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This prospective observational pilot study evaluated the aerosolized intranasal route for dexmedetomidine as a safe, effective, and efficient option for infant and pediatric sedation for computed tomography imaging. The mean time to sedation was 13.4 minutes, with excellent image quality, no failed sedations, or significant adverse events. Registered with ClinicalTrials.gov: NCT01900405.
Medical subject headings
- Procedural Sedation
- Dexmedetomidine
- Tomography, X-Ray Computed